Chemical Profiling and UPLC-qTOF-MS/MS-Based Metabolomics of Three Different Parts of Edgeworthia chrysantha and Identification of Glucose Uptake-Enhancing Compounds
Nutrients · 2025
DOI: 10.3390/nu17162684 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Jin-Pyo An und 6 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 151-742, Republic of Korea. Hauptthemen laut MEDLINE: Metabolomics, Glucose, Plant Extracts. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Basic Science Research Program Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT in Korea, Basic Science Research Programs.
Abstract (Originalsprache)
Background/Objectives: Edgeworthia chrysantha is rich in coumarin and flavonoid dimers, which may exhibit diverse pharmacological activities. However, to date, no metabolomics studies have been conducted and its bioactive constituents related to glucose metabolism remain uncharacterized. This study aimed to conduct a comprehensive chemical analysis combined with bioactivity assays to evaluate its efficacy in promoting glucose uptake.
Methods
Chemical profiling of three parts (leaf, stem, and root) of E. chrysantha was performed using UPLC-Q-TOF-MS/MS spectrometry, followed by metabolomics analysis. Based on the chemical profiles and glucose uptake activity, compounds were isolated from the root. Their structures were elucidated using spectroscopic techniques, including UV, NMR, and mass spectrometry. The glucose uptake activity of the isolated compounds was assessed using a 2-NBDG assay.
Results
Metabolic analysis revealed distinct chemical compositions among the plant parts. Dimeric coumarins and biflavonoids were abundant in the root, whereas flavonoid monomers were predominant in the leaf. Bioactivity-guided isolation yielded nine compounds (1–9), among which compound 1, a newly identified coumarin glycoside, exhibited significant glucose uptake-enhancing activity. Molecular docking analysis further suggested that compound 1 activates AMPK through an allosteric site, thereby promoting glucose uptake.
Conclusions
These findings provide a comprehensive chemical and metabolomic characterization of E. chrysantha and highlight its potential as a functional food ingredient for glucose-lowering effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 151-742, Republic of Korea.
- College of Natural Sciences, Can Tho University, Campus II, Can Tho 90000, Vietnam.
ORCID-Profile: Van-Hieu Mai, Jorge-Eduardo Ponce-Zea, Gi Hyeon Seong, Won Keun Oh
Förderung
- Basic Science Research Program Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT in Korea
- Basic Science Research Programs
Zitieren
APA
An, J. P., Han, S., Mai, V. H., Ponce-Zea, J. E., Seong, G. H., Ha, T. K., & Oh, W. K. (2025). Chemical Profiling and UPLC-qTOF-MS/MS-Based Metabolomics of Three Different Parts of Edgeworthia chrysantha and Identification of Glucose Uptake-Enhancing Compounds. Nutrients. https://doi.org/10.3390/nu17162684
Vancouver
An JP, Han S, Mai VH, Ponce-Zea JE, Seong GH, Ha TK, et al. Chemical Profiling and UPLC-qTOF-MS/MS-Based Metabolomics of Three Different Parts of Edgeworthia chrysantha and Identification of Glucose Uptake-Enhancing Compounds. Nutrients. 2025. doi:10.3390/nu17162684
BibTeX
@article{An2025,
author = {An, Jin-Pyo and Han, Sohee and Mai, Van-Hieu and Ponce-Zea, Jorge-Eduardo and Seong, Gi Hyeon and Ha, Thi-Kim-Quy and Oh, Won Keun},
title = {Chemical Profiling and UPLC-qTOF-MS/MS-Based Metabolomics of Three Different Parts of Edgeworthia chrysantha and Identification of Glucose Uptake-Enhancing Compounds},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17162684}
}
EUVIMED